255 related articles for article (PubMed ID: 19356516)
1. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies.
Afonso LC; Bernal J; Bax JJ; Abraham TP
JACC Cardiovasc Imaging; 2008 Nov; 1(6):787-800. PubMed ID: 19356516
[TBL] [Abstract][Full Text] [Related]
2. [The role of real-time three-dimensional echocardiography in the evaluation of hypertrophic cardiomyopathy].
Nemes A; Geleijnse ML; Soliman OI; Anwar AM; Vletter WB; McGhie JS; Csanády M; Forster T; Ten Cate FJ
Orv Hetil; 2009 Oct; 150(42):1925-31. PubMed ID: 19812010
[TBL] [Abstract][Full Text] [Related]
3. Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.
Losi MA; Nistri S; Galderisi M; Betocchi S; Cecchi F; Olivotto I; Agricola E; Ballo P; Buralli S; D'Andrea A; D'Errico A; Mele D; Sciomer S; Mondillo S;
Cardiovasc Ultrasound; 2010 Mar; 8():7. PubMed ID: 20236538
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of Mitral Subvalvular Apparatus in Hypertrophic Cardiomyopathy: Role of Intraoperative 3D Transesophageal Echocardiography.
Sonny A; Sale S; Smedira NG
Anesth Analg; 2016 Nov; 123(5):1094-1097. PubMed ID: 27607478
[No Abstract] [Full Text] [Related]
5. Transthoracic Doppler echocardiographic assessment of left anterior descending coronary artery and intramyocardial small coronary artery flow in patients with hypertrophic cardiomyopathy.
Minagoe S
J Cardiol; 2001; 37 Suppl 1():115-20. PubMed ID: 11433814
[TBL] [Abstract][Full Text] [Related]
6. Pathological and physiological left ventricular hypertrophy: echocardiography for differentiation.
Chelliah RK; Senior R
Future Cardiol; 2009 Sep; 5(5):495-502. PubMed ID: 19715413
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls in the echo-Doppler diagnosis of hypertrophic cardiomyopathy.
Movsowitz HD; Movsowitz C; Jacobs LE; Kotler MN
Echocardiography; 1993 Mar; 10(2):167-79. PubMed ID: 10148403
[TBL] [Abstract][Full Text] [Related]
8. The role of echocardiography in management of hypertrophic cardiomyopathy.
Haland TF; Edvardsen T
J Echocardiogr; 2020 Jun; 18(2):77-85. PubMed ID: 31858431
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic advances in hypertrophic cardiomyopathy: Three-dimensional and strain imaging echocardiography.
Inciardi RM; Galderisi M; Nistri S; Santoro C; Cicoira M; Rossi A
Echocardiography; 2018 May; 35(5):716-726. PubMed ID: 29577429
[TBL] [Abstract][Full Text] [Related]
10. Determinants of coronary flow abnormalities in obstructive type hypertrophic cardiomyopathy: noninvasive assessment by transthoracic Doppler echocardiography.
Celik S; Dagdeviren B; Yildirim A; Gorgulu S; Uslu N; Eren M; Gurol T; Ozen E; Tezel T
J Am Soc Echocardiogr; 2004 Jul; 17(7):744-9. PubMed ID: 15220899
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of strain indexes and prognosis of patients with cardiac amyloidosis with preserved LVEF by three-dimensional speckle tracking imaging].
Yu ZH; Wu BF; Zhou YJ; Yan H; Zhu JH
Zhonghua Yi Xue Za Zhi; 2018 Dec; 98(47):3842-3847. PubMed ID: 30585027
[No Abstract] [Full Text] [Related]
12. Important advances in technology: echocardiography.
Nagueh SF; Quiñones MA
Methodist Debakey Cardiovasc J; 2014; 10(3):146-51. PubMed ID: 25574341
[TBL] [Abstract][Full Text] [Related]
13. Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management.
Williams LK; Frenneaux MP; Steeds RP
Eur J Echocardiogr; 2009 Dec; 10(8):iii9-14. PubMed ID: 19889657
[TBL] [Abstract][Full Text] [Related]
14. Speckle tracking: distinction of physiologic from pathologic LVH?
van der Wall EE; Delgado V; Holman ER; Bax JJ
Int J Cardiovasc Imaging; 2011 Jan; 27(1):101-4. PubMed ID: 20734233
[No Abstract] [Full Text] [Related]
15. New echocardiographic technologies in the clinical management of hypertensive heart disease.
Di Bello V; Galderisi M; de Gregorio C; Ansalone G; Dini FL; Di Salvo G; Gallina S; Mele D; Sciomer S; Montisci R; Mondillo S; Marino PN;
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):997-1006. PubMed ID: 18163010
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography.
Kato TS; Noda A; Izawa H; Yamada A; Obata K; Nagata K; Iwase M; Murohara T; Yokota M
Circulation; 2004 Dec; 110(25):3808-14. PubMed ID: 15583080
[TBL] [Abstract][Full Text] [Related]
17. The role of echocardiography in hypertrophic cardiomyopathy.
Williams LK; Gruner CH; Rakowski H
Curr Cardiol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618305
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic and Doppler studies in hypertrophic cardiomyopathy.
Sasson Z; Rakowski H; Wigle ED; Popp R
Cardiol Clin; 1990 May; 8(2):217-32. PubMed ID: 2189558
[TBL] [Abstract][Full Text] [Related]
19. Live three-dimensional transthoracic contrast echocardiographic assessment of apical hypertrophic cardiomyopathy.
Frans EE; Nanda NC; Patel V; Fonbah WS; Vengala S; Mehmood F; Bodiwala K
Echocardiography; 2005 Sep; 22(8):686-9. PubMed ID: 16174126
[TBL] [Abstract][Full Text] [Related]
20. Tissue Doppler imaging in hypertrophic cardiomyopathy: impact of intraventricular obstruction on longitudinal left ventricular function.
Cardim N; Torres D; Morais H; Cândido A; Duarte R; Longo S; Ferreira T; Pereira A; Gouveia A; Reis RP; Correia JM
Rev Port Cardiol; 2002 Mar; 21(3):271-97. PubMed ID: 12017801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
